v3.25.2
Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense $ 0 $ 0 $ 57 $ 0 $ 0 $ 0
Research and Development            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense     57 0    
General and Administrative            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense     0 0    
IKENA ONCOLOGY INC            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense 458 1,279 1,362 3,280 5,295 7,632
IKENA ONCOLOGY INC | Research and Development            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense 45 400 192 1,177 1,655 3,937
IKENA ONCOLOGY INC | General and Administrative            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense 413 879 994 1,840 3,377 $ 3,695
IKENA ONCOLOGY INC | Restructuring and Other Charges            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Total stock-based compensation expense $ 0 $ 0 $ 176 $ 263 $ 263